Why measure cholesterol after myocardial infarction, and when?
作者信息
Oliver M F
出版信息
Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1641-2. doi: 10.1136/bmj.289.6459.1641.
Abstract
摘要
相似文献
1
Why measure cholesterol after myocardial infarction, and when?为什么要在心肌梗死后测量胆固醇，以及何时测量？
Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1641-2. doi: 10.1136/bmj.289.6459.1641.
2
[Value of lipid lowering drugs after myocardial infarction: results of the coronary drug project 1975 (author's transl)].心肌梗死后降脂药物的价值：1975年冠状动脉药物项目的结果（作者译）
Schweiz Rundsch Med Prax. 1975 Sep 16;64(37):1167-8.
3
The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.冠状动脉药物项目——关于雌激素、右旋甲状腺素、氯贝丁酯和烟酸的研究结果。
Adv Exp Med Biol. 1977;82:52-75. doi: 10.1007/978-1-4613-4220-5_6.
4
[Lipid reduction and myocardial infarct].[血脂降低与心肌梗死]
Lakartidningen. 1975 Apr 9;72(15):1541-2.
5
Editorial: Lipid-lowering drugs after myocardial infarction.社论：心肌梗死后的降脂药物
Lancet. 1975 Mar 1;1(7905):501-2.
6
Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid.氯贝丁酯与烟酸联合治疗对心肌再梗死的降低作用。
Atherosclerosis. 1977 Sep;28(1):81-6. doi: 10.1016/0021-9150(77)90201-5.
7
[Hypercholesteremia].[高胆固醇血症]
Dtsch Med Wochenschr. 1972 Nov 3;97(44):1720-1.
8
[Serum lipid-lowering drugs following myocardial infarction].[心肌梗死后的血清降脂药物]
Dtsch Med Wochenschr. 1975 Aug 1;100(31):1611-2.
9
Editorial: After a coronary.社论：冠心病之后
Br Med J. 1975 Apr 19;2(5963):103-5.
引用本文的文献
1
A network analysis of the propagation of evidence regarding the effectiveness of fat-controlled diets in the secondary prevention of coronary heart disease (CHD): Selective citation in reviews.网络分析证据在脂肪控制饮食在冠心病（CHD）二级预防中的有效性传播：综述中的选择性引用。
PLoS One. 2018 May 24;13(5):e0197716. doi: 10.1371/journal.pone.0197716. eCollection 2018.
2
The role of risk factors in heart attacks occurring in men with pre-existing ischaemic heart disease.危险因素在已有缺血性心脏病的男性发生心脏病发作中的作用。
Br Heart J. 1988 Nov;60(5):404-10. doi: 10.1136/hrt.60.5.404.
3
After the infarct.梗死发生后。
Br Med J (Clin Res Ed). 1987 Dec 5;295(6611):1431-2. doi: 10.1136/bmj.295.6611.1431.
4
Current clinical laboratory practice: investigation of plasma lipids--which tests and when?当前临床实验室实践：血浆脂质检测——检测哪些项目以及何时检测？
Br Med J (Clin Res Ed). 1986 Jun 21;292(6536):1652-4. doi: 10.1136/bmj.292.6536.1652.
本文引用的文献
1
Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease.氯贝丁酯与烟酸联合治疗对缺血性心脏病的影响。
Atherosclerosis. 1980 Sep;37(1):129-42. doi: 10.1016/0021-9150(80)90100-8.
2
Hypercholesterolaemia and coronary heart disease: an answer.高胆固醇血症与冠心病：一个答案。
Br Med J (Clin Res Ed). 1984 Feb 11;288(6415):423-4. doi: 10.1136/bmj.288.6415.423.
3
Studies of male survivors of myocardial infarction. XII. Relation of serum lipids and lipoproteins to survival over a 10-year period.心肌梗死男性幸存者的研究。十二、血清脂质和脂蛋白与10年生存率的关系。
Can Med Assoc J. 1970 Oct 24;103(9):927-31.
4
Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.使用氯贝丁酯的二级预防试验：关于纽卡斯尔和苏格兰试验的联合评论
Br Med J. 1971 Dec 25;4(5790):784-6. doi: 10.1136/bmj.4.5790.784.
5
Plasma-lipid changes after myocardial infarction.
Lancet. 1971 Nov;2(7732):997-1001. doi: 10.1016/s0140-6736(71)90322-9.
6
Natural history of obstructive coronary artery disease: ten-year study of 601 nonsurgical cases.
Prog Cardiovasc Dis. 1978 Jul-Aug;21(1):53-78. doi: 10.1016/s0033-0620(78)80004-8.
Zotero 插件